All News

The FDA determined that individuals with weakened immune systems — which include patients with cancer — may benefit from a third dose of Pfizer-BioNTech’s and Moderna’s COVID-19 vaccines.

On behalf of Hope for Stomach Cancer, Dr. Yanghee Woo speaks with CURE® about risk factors for gastric cancer and the alarming rise in cases in young adults.

Adolescent and young adult patients are more represented than previously expected in clinical trials. However, their outcomes still lag behind the younger and older populations.

Multiple cancer drugs have been approved by the FDA in the last few months.

A four-time cancer survivor shares the advice her father gave her as a young child during her first journey with cancer. The words he uttered made her shift how she has looked at life.

In this episode of the “CURE® Talks Cancer” podcast, the hosts of the ‘Stage 4 Clinger’ podcast share the story of their cancer and caregiver journeys and how it led to the conception of their podcast.

Cancer survivors who identify as LGBTQ reported a lack of access to tailored resources and support groups and fear of discrimination.

Patients on Keytruda/Lenvima lived for an average of 23.9 months without their disease progressing, compared to those on a different treatment, with an average of 9.3 months.

The COVID-19 pandemic may have worsened existing health disparities in cancer care. Vaccines may be the next step forward.

“More and more (patients and physicians) need to work together in partnership throughout the cancer journey in order to optimize and make the journey the best possible that we can for every single patient,” says an expert from the Roswell Park Comprehensive Cancer Center.

A woman shares her thoughts on the number of oral medications she's taken to treat her metastatic breast cancer.

There are now more oral cancer treatments than ever, highlighting the importance of patients independently taking their drugs as prescribed.

Heating chemotherapy and administering it into the abdominal cavity allows children with desmoplastic small round cell tumors to be treated with minimal side effects.

The FDA will speed up the review of Keytruda to treat patients with kidney cancer after they’ve undergone surgery.

"Dr. Ramirez is passionate about lung cancer and his research," writes Kristen Gurba in a submission for the CURE® Lung Cancer Heroes® Award.

Treatment for acute lymphoblastic leukemia can be long and difficult at times, but the end goal is curing the disease.

A woman living with Lynch syndrome discusses the importance of preventive strategies.

Children with cancer who carry the specific genetic variant may be at a three times increased risk of developing cisplatin-induced hearing loss compared to those who do not.

A patient with MDS writes about facing fears during the treatment journey.

Lung cancer can happen to anyone, regardless of their smoking history. Two advocates discussed the need to end the stigma around the disease.

Outcomes in patients with CLL continue to improve with the emergence of targeted drugs and immunotherapy.

More people are aware of the disparities LGBTQ patients face, but prohibitive legislature could be moving the needle backward when it comes to equality in care.

A woman writes about how being labeled a ‘cancer patient’ gives her a feeling of lost identity.

Blood cancer survivors are living longer than ever, making safe pain management an important concern.

A woman writes about the feeling of ambivalence that comes with each milestone in the treatment journey for her breast cancer.

A patient writes about the impact Dr. Aaron Mansfield had on her during treatment.

From a 6-year-old cancer survivor visiting all 50 states to give wagons to pediatric patients to Kathy Griffin taking an honest look at cancer and opioid addiction, here’s what’s happening in the cancer space this week.

Experts from the St. Jude’s Children’s Research Hospital advise young-adult childhood cancer survivors to increase their physical activity levels, eat well and stay socially active to reduce their risk of becoming frail and prevent cognitive decline.